NEW YORK (GenomeWeb) – Tempus said today that it is collaborating with the Basser Center for BRCA at the University of Pennsylvania's Abramson Cancer Center with the goal of improving and personalizing treatment for patients with heritable BRCA mutations.

Launched in 2015, Tempus is building its business around offering genomic sequencing services and proprietary analytics to clinicians and clinical research groups.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.